These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 13855167)

  • 1. Toxicological and clinical evaluation of a new nitrogen mustard, 2-[di-2(chloroethyl)-aminomethyl]benzimidazole.
    ULTMANN JE; THOMPSON HG; HIRSCHBERG E; ZAIDENWEBER J; GELLHORN A
    Cancer Res; 1959 Aug; 19():719-25. PubMed ID: 13855167
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of P-Di-(2-chloroethyl)-aminophenylalanine on malignant tumors.
    MILLER BJ; KISTENMACHER JC
    J Am Med Assoc; 1960 May; 173():14-21. PubMed ID: 14422473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical toxicology of nitrogen mustards].
    SCHMIDT L; SCHENNETTEN F
    Z Gesamte Inn Med; 1956 May; 11(10):477-80. PubMed ID: 13353313
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.
    MILLER DG; LAWRENCE W
    Arch Surg; 1962 Sep; 85():430-41. PubMed ID: 14473972
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of sodium thisulfate as a systemic neutralizer of nitrogen mustard: report of 12 patients.
    OWENS G; HATIBOGLU I
    Ann Surg; 1961 Dec; 154(6):895-7. PubMed ID: 14482909
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiments on the therapeutic index of nitrogen mustard (HN2).
    WHITE LP
    Acta Unio Int Contra Cancrum; 1960; 16():800-6. PubMed ID: 13844375
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.
    JACOBSON LO; SPURR CL
    J Am Med Assoc; 1946 Oct; 132():263-71. PubMed ID: 20997209
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosome damage during nitrogen mustard therapy. A case report.
    CONEN PE; LANSKY GS
    Br Med J; 1961 Oct; 2(5259):1055-7. PubMed ID: 13880833
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the experimental production of phocomeli in the chick embryo using nitrogen mustard].
    SALZGEBER B
    C R Hebd Seances Acad Sci; 1962 May; 254():3591-3. PubMed ID: 14496542
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against systemic toxicity due to nitrogen mustard.
    ROSS CA; CAR BERRY DM; KRAUS GE
    Surg Forum; 1960; 11():43-5. PubMed ID: 13743580
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications following pelvic perfusion with nitrogen mustard for cancer.
    SHOLES DM; JENKINS HH
    J Tn State Med Assoc; 1960 Apr; 53():134-9. PubMed ID: 14446152
    [No Abstract]   [Full Text] [Related]  

  • 12. New nitrogen mustards in the control of leukemia.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1959 Dec; 131():455-61. PubMed ID: 14441249
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual allergic reaction to nitrogen mustard.
    MARQUEZ AH
    Am Pract Dig Treat; 1961 Apr; 12():271-4. PubMed ID: 13767085
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard.
    NISSEN-MEYER R; HOST H
    Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of pH on the toxicity of nitrogen mustard.
    WHITE LP
    Science; 1960 Apr; 131(3406):1041-3. PubMed ID: 13844376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of triflupromazine hydrochloride for control of emetic reactions to nitrogen mustard therapy.
    BLAKE JM; HAYFORD FC
    N Y State J Med; 1960 Jul; 60():2114-7. PubMed ID: 13801261
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiosulfate protection against the toxic effects of nitrogen mustard in perfusion of the liver.
    FOSTER JH; LEWIS MR; JACOBS JK
    Am Surg; 1962 Jul; 28():461-4. PubMed ID: 13894237
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of nephrotic syndromes with nitrogen mustards].
    LAGRUE G; FONTAINE JL; SAMARCQ P; FRITEL D; MILLIEZ P
    Sem Med Prof Med Soc; 1961 Mar; 37():781-9. PubMed ID: 13758269
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective action of autologous marrow against nitrogen mustard toxicity.
    BLACK MM; SPEER FD; STONE ML
    Ann Intern Med; 1959 Sep; 51():517-25. PubMed ID: 13801160
    [No Abstract]   [Full Text] [Related]  

  • 20. The present status of nitrogen mustard therapy in dermatology.
    EPSTEIN NN
    Urol Cutaneous Rev; 1949 Oct; 53(10):628-30. PubMed ID: 18141450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.